Variablea | All-cause ER visits | All-cause hospitalizations | MS-specific ER visits | MS-specific hospitalizations |
---|---|---|---|---|
MS Relapse ≥2 | 1.33 (1.15-1.54)b | 1.97 (1.67-2.32)b | 1.72 (1.43-2.08)b | 3.25 (2.47-4.29)b |
Age group | ||||
(36–45, Ref: 18–35) | 0.81 (0.70-0.93)c | 0.66 (0.54-0.80)b | 0.82 (0.67-1.01) | 1.20 (0.79-1.83) |
(46–55, Ref: 18–35) | 0.75 (0.65-0.85)b | 0.79 (0.66-0.94)c | 0.70 (0.58-0.85)d | 0.95 (0.63-1.43) |
(56–65, Ref: 18–35) | 0.83 (0.72-0.95)c | 1.02 (0.86-1.22) | 0.70 (0.58-0.85)d | 0.82 (0.54-1.25) |
(65+, Ref: 18–35) | 1.12 (0.95-1.32) | 1.70 (1.38-2.08)b | 0.71 (0.55-0.90)c | 0.92 (0.55-1.52) |
Female (Ref: male) | 1.10 (1.01-1.20)c | 0.95 (0.85-1.06) | 1.07 (0.93-1.22) | 0.87 (0.68-1.12) |
Region | ||||
North Central (Ref: Northeast) | 1.16 (1.03-1.30)c | 1.09 (0.94-1.27) | 1.60 (1.32-1.95)b | 1.24 (0.88-1.76) |
South (Ref: Northeast) | 1.03 (0.91-1.16) | 1.01 (0.87-1.18) | 1.33 (1.09-1.62)c | 0.97 (0.68-1.38) |
West (Ref: Northeast) | 0.95 (0.84-1.08) | 0.93 (0.78-1.10) | 1.64 (1.33-2.02)b | 0.82 (0.54-1.22) |
Unknown (Ref: Northeast) | 1.63 (0.54-4.92) | 1.04 (0.22-4.85) | 1.08 (0.14-8.55) | 7.77 (1.57-38.53)c |
Non-Employee (Ref: Employee) | 1.07 (1.00-1.15) | 1.06 (0.97-1.17) | 1.12 (1.00-1.25)c | 1.35 (1.09-1.67)c |
Plan type | ||||
HMO and POS capitation (Ref: FFS) | 0.94 (0.85-1.04) | 0.93 (0.81-1.06) | 1.13 (0.98-1.30) | 0.80 (0.58-1.11) |
Missing (Ref: FFS) | 0.76 (0.59-0.98) | 0.79 (0.57-1.11) | 0.91 (0.63-1.32) | 0.67 (0.27-1.65) |
CCI | 1.13 (1.10-1.16)b | 1.21 (1.17-1.25)b | 1.04 (1.0-1.09) | 1.09 (1.01-1.17)c |
Any MS symptoms | 1.53 (1.40-1.67)b | 1.47 (1.30-1.66)b | 1.56 (1.36-1.80)b | 1.70 (1.24-2.33)c |
Any DMT use | 0.87 (0.80-0.94)c | 0.79 (0.72-0.87)b | 0.96 (0.85-1.07) | 1.24 (0.98-1.57) |
All-cause ER visits | 2.50 (2.31-2.71)b | 1.75 (1.58-1.94)b | 2.33 (2.07-2.62)b | 1.86 (1.47-2.35)b |
All-cause hospitalizations | 1.37 (1.24-1.52)b | 2.43 (2.16-2.73)b | 1.46 (1.27-1.69)b | 3.12 (2.43-4.01)b |